This page lists 11 myasthenia gravis doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
Quick answer
This page lists 11 myasthenia gravis doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Myasthenia Gravis doctors in India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
About the Condition
What is Myasthenia Gravis?
Myasthenia gravis (MG) is a chronic autoimmune disorder in which the immune system mistakenly attacks the communication point between nerves and muscles, causing fluctuating muscle weakness that can affect the eyes, face, swallowing, breathing, and limb strength. Left inadequately managed, it carries meaningful risks including myasthenic crisis — a potentially life-threatening episode of respiratory muscle failure that may require emergency ventilatory support. Associated conditions such as thymoma (a tumour of the thymus gland), thyroid disorders, and other autoimmune diseases are found at higher rates in people with MG and must be considered during evaluation. A thorough assessment of symptom pattern, disease severity, and any underlying structural or immune abnormalities guides all treatment decisions, which should always be made in partnership with a qualified specialist.
Individual assessmentEvery case is different
Complete evaluationUnderstand the condition first
Specialist reviewChoose the right approach
Medical assessment helps clarify severity and identify appropriate options.
Treatment options for Myasthenia Gravis
Care may include lifestyle changes, medical treatment, specialist review or a procedure, depending on the diagnosis, associated conditions and individual goals. The options below are associated with this condition in the GAF Healthcare directory.
Myasthenia Gravis (MG) is a chronic autoimmune neuromuscular disorder that causes weakness and rapid fatigue of voluntary muscles, including those controlling eye movement, facial expression, chewing, swallowing, and breathing.
Why it may be consideredTreatment aims to improve neuromuscular transmission, suppress the abnormal immune response, and manage acute exacerbations (myasthenic crisis). India offers advanced neurology and thoracic surgery programs, including thymectomy and immunotherapy, at a fraction of Western costs.
KIMS Hospitals, Secunderabad Hyderabad, India18+ Years experience
Why consider this doctor?
18+ years of experience in Neurologist
Consultant Neurologist, KIMS Hospitals, Secunderabad — August 2017 to present, with a focus on movement disorders, stroke, epilepsy, and neuromuscular conditions.
Active member of the DBS and MRI-guided Focused Ultrasound (MRgFUS) program at KIMS, contributing to patient evaluation, postoperative programming, and long-term management.
KIMS Hospitals, Thane Mumbai, India14+ Years experience
Why consider this doctor?
14+ years of experience in Neurologist
Currently serving as Consultant Neurologist in the Department of Neurology at KIMS Hospitals, Thane.
Established the first privately owned syncope and autonomic function assessment lab in India, expanding diagnostic access for patients with autonomic disorders.
Expertise & Procedures
Acute Stroke Thrombolysis & Management
Epilepsy Evaluation & Drug Management
Botulinum Toxin Injections for Dystonia & Spasticity
Post-Doctoral Fellowship in Neuromuscular Disorders, DrNB (Neurology), MD (General Medicine), MBBS, International Certification in Epilepsy for Neurologists, Certification in Epilepsy for Neurologists, Certification in Headache
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Many international patients consider India for myasthenia gravis treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
How this directory is built
Doctors are matched using the specialty, location, condition (Myasthenia Gravis) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Myasthenia Gravis in India
What is Myasthenia Gravis?
Myasthenia gravis is a chronic autoimmune neuromuscular disease in which antibodies impair or destroy receptors at the junction between nerves and voluntary muscles, producing characteristic weakness that typically worsens with activity and improves with rest.
What are the symptoms and health risks of Myasthenia Gravis?
Common presentations include drooping of one or both eyelids (ptosis), double vision, difficulty swallowing or speaking, facial muscle weakness, and fatigue or weakness in the arms and legs that fluctuates throughout the day and worsens with sustained effort. In some individuals, weakness of the breathing muscles can develop, representing a medical emergency. Experiencing any combination of these symptoms does not confirm a diagnosis of myasthenia gravis, as several other neurological and muscular conditions can produce similar features.
How is Myasthenia Gravis diagnosed?
Diagnosis typically involves a detailed clinical history and neurological examination, followed by blood tests to detect acetylcholine receptor (AChR) antibodies or, in seronegative cases, muscle-specific kinase (MuSK) or LRP4 antibodies. Electrophysiological studies — specifically repetitive nerve stimulation and single-fibre electromyography (SFEMG), the most sensitive electrodiagnostic test available — are used to confirm impaired neuromuscular transmission. Imaging of the chest (CT or MRI) is routinely performed to screen for thymoma or thymic hyperplasia, and disease severity is often classified using the Myasthenia Gravis Foundation of America (MGFA) clinical classification, which ranges from Class I (ocular involvement only) through Class V (intubation required), helping to guide treatment intensity.
How is Myasthenia Gravis treated?
Treatment is highly individualised based on MGFA class, antibody profile, age, the presence of thymoma, and overall health, and ranges from medication alone in mild cases to surgical and advanced immunological interventions in more severe or refractory disease. Symptom control is typically initiated with acetylcholinesterase inhibitors, while long-term immune modulation is pursued with corticosteroids and steroid-sparing immunosuppressants; for eligible patients — particularly those under 60 or those found to have thymoma — thymectomy (surgical removal of the thymus) has been shown to improve long-term outcomes. In myasthenic crisis or rapidly worsening disease, short-term rescue therapies such as plasmapheresis (plasma exchange) or intravenous immunoglobulin (IVIg) are used to stabilise the patient quickly.
Can Myasthenia Gravis be treated without surgery?
The majority of patients with myasthenia gravis are managed primarily through non-surgical means, including acetylcholinesterase inhibitors (such as pyridostigmine) for symptomatic relief, corticosteroids, and long-term immunosuppressant medications such as azathioprine, mycophenolate mofetil, or tacrolimus. Newer targeted biological therapies — including complement inhibitors (eculizumab, ravulizumab) and neonatal Fc receptor (FcRn) antagonists (efgartigimod, rozanolixizumab) — have expanded non-surgical options for refractory cases. Monitoring, dose adjustments, and avoidance of medications known to exacerbate MG are ongoing components of non-surgical care; the appropriateness of any specific agent or regimen depends entirely on individual assessment by a treating clinician.
When is Myasthenia Gravis Treatment considered for Myasthenia Gravis?
Myasthenia Gravis Treatment may be considered when conservative or medical options have not achieved enough improvement, or when the severity of the condition warrants it. The decision depends on clinical assessment, expected benefits and individual risks.
Which doctor treats Myasthenia Gravis?
Myasthenia gravis is primarily evaluated and managed by a neurologist, specifically one with expertise in neuromuscular disorders; where thymoma is identified or thymectomy is being considered, a thoracic surgeon experienced in thymic surgery becomes an essential part of the care team. In complex or refractory cases, input from a clinical immunologist or a specialist in neuro-ophthalmology (for isolated ocular MG) may also be sought.
How do I choose a doctor for Myasthenia Gravis?
When selecting a specialist or facility, it is worth asking about their experience managing MG across the full MGFA severity spectrum, whether the centre offers multidisciplinary input including thoracic surgery, respiratory medicine, and immunology, and what follow-up and crisis management protocols are in place — given that myasthenic crisis can require urgent, coordinated care.
What documents do international patients need to share for a medical evaluation?
Share a medical summary, investigation and imaging or biopsy reports where relevant, a current medication list, previous diagnoses and related treatment records. Provide clear copies with translation where needed.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team helps review initial medical information, connect you with suitable doctors and hospitals, explain next steps and indicative estimates, and organise a treatment plan before travel.
